Annexin A13 (ANXA13) Peptide
ANXA13
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Annexin A13 (ANXA13) products
- Annexin A13 (ANXA13)
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ANXA13 antibody (Catalog #: ARP36590_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Annexin A13 (ANXA13)
- Background
-
The ANXA13 gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. The specific function of ANXA13 has not yet been determined, however, it is associated with the plasma membrane of undifferentiated, proliferating endothelial cells and differentiated villus enterocytes.
Alias Symbols: ISA, ANX13
Protein Interaction Partner: KIFC3,NEDD4,NMT1
Protein Size: 357 - Molecular Weight
- 39 kDa
- Gene ID
- 312
- NCBI Accession
- NM_001003954, NP_001003954
- UniProt
- P27216
-
You are here:
